From Alzheimer’s to Zebrafish: Eclectic Science and Regulatory Stories 68
References
1. FDA approval of Listeria-specific bacteriophage preparation on ready-to-eat (RTE) meat and poultry products.
CFSAN/Office of Food Additive Safety. August 2006. www.cfsan.fda.gov/~dms/opabacqa.html. Accessed 27
August 2008.
2. Summers WC. History of phage research and phage therapy. In: Waldor MK, Friedman DI, Adhya SL, eds.
Phages: Their Role in Bacterial Pathogenesis and Biotechnology. Washington, DC: ASM Press 2005:3-17.
3. Twort FE. An investigation on the nature of ultra-microscopic viruses. Lancet. 1915 2:1241-1243.
4. Hausler T. Viruses vs. Superbugs: A Solution to the Antibiotics Crisis? London, UK: Macmillan 2007.
5. Summers WC. Felix d’Herelle and the Origins of Molecular Biology. New Haven, CT: Yale University Press 1999.
6. D’Herelle F. Sur un microbe invisible antagoniste des bacilles dysenteriques. CR Acad Sci. 1917 165:373-375.
7. Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother. 2001 45:649-659.
8. Thacker PD. Set a microbe to kill a microbe: drug resistance renews interest in phage therapy. JAMA.
2003 290:3183-3185.
9. Hendrix RW. Bacteriophage evolution and the role of phages in host evolution. In: Waldor MK, Friedman
DI, Adhya SL, eds. Phages: Their Role in Bacterial Pathogenesis and Biotechnology. Washington, DC: ASM Press
2005:55-65.
10. Ibid.
11. Op cit 4.
12. Op cit 9.
13. Op cit 7.
14. Bruynoghe R, Maisin J. Essais de therapeutique au moyen du bacteriophage. CR Soc Biol. 1921 85:1120-1121.
15. Op cit 4.
16. Op cit 7.
17. Op cit 4.
18. Merril CR, Biswas B, Carlton R, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci
USA. 1996 93:3188-3192.
19. Ibid.
20. Op cit 7.
21. Op cit 4.
22. Cislo M, Dabrowski M, Weber-Dabrowska B, Woyton A. Bacteriophage treatment of suppurative skin infec-
tions. Arch Immunol Ther Exp. 1987 2:175-2183.
23. Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A. Results of bacteriophage treatment
of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Exp. 1987:35:569-583.
24. Prins JM, van Deventer SJ, Kuijper EJ, Speelman P. Clinical relevance of antibiotic-induced endotoxin release.
Antimicrob Agents Chemother. 1994 38:1211-1218.
25. Op cit 7.
26. Ibid.
27. Op cit 4.
28. McKinstry M, Edgar R. Use of phages in therapy and bacterial detection. In: Waldor MD, Friedman DI, Adhya
SL, eds. Phages: Their Role in Bacterial Pathogenesis and Biotechnology. Washington, DC: ASM Press 2005:430-440.
Reprinted with permission from US Pharmacist, October 2008, US Pharm 2008 33(10):46-51. Copyright © 2008 Jobson
Medical Information LLC.
References
1. FDA approval of Listeria-specific bacteriophage preparation on ready-to-eat (RTE) meat and poultry products.
CFSAN/Office of Food Additive Safety. August 2006. www.cfsan.fda.gov/~dms/opabacqa.html. Accessed 27
August 2008.
2. Summers WC. History of phage research and phage therapy. In: Waldor MK, Friedman DI, Adhya SL, eds.
Phages: Their Role in Bacterial Pathogenesis and Biotechnology. Washington, DC: ASM Press 2005:3-17.
3. Twort FE. An investigation on the nature of ultra-microscopic viruses. Lancet. 1915 2:1241-1243.
4. Hausler T. Viruses vs. Superbugs: A Solution to the Antibiotics Crisis? London, UK: Macmillan 2007.
5. Summers WC. Felix d’Herelle and the Origins of Molecular Biology. New Haven, CT: Yale University Press 1999.
6. D’Herelle F. Sur un microbe invisible antagoniste des bacilles dysenteriques. CR Acad Sci. 1917 165:373-375.
7. Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother. 2001 45:649-659.
8. Thacker PD. Set a microbe to kill a microbe: drug resistance renews interest in phage therapy. JAMA.
2003 290:3183-3185.
9. Hendrix RW. Bacteriophage evolution and the role of phages in host evolution. In: Waldor MK, Friedman
DI, Adhya SL, eds. Phages: Their Role in Bacterial Pathogenesis and Biotechnology. Washington, DC: ASM Press
2005:55-65.
10. Ibid.
11. Op cit 4.
12. Op cit 9.
13. Op cit 7.
14. Bruynoghe R, Maisin J. Essais de therapeutique au moyen du bacteriophage. CR Soc Biol. 1921 85:1120-1121.
15. Op cit 4.
16. Op cit 7.
17. Op cit 4.
18. Merril CR, Biswas B, Carlton R, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci
USA. 1996 93:3188-3192.
19. Ibid.
20. Op cit 7.
21. Op cit 4.
22. Cislo M, Dabrowski M, Weber-Dabrowska B, Woyton A. Bacteriophage treatment of suppurative skin infec-
tions. Arch Immunol Ther Exp. 1987 2:175-2183.
23. Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A. Results of bacteriophage treatment
of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Exp. 1987:35:569-583.
24. Prins JM, van Deventer SJ, Kuijper EJ, Speelman P. Clinical relevance of antibiotic-induced endotoxin release.
Antimicrob Agents Chemother. 1994 38:1211-1218.
25. Op cit 7.
26. Ibid.
27. Op cit 4.
28. McKinstry M, Edgar R. Use of phages in therapy and bacterial detection. In: Waldor MD, Friedman DI, Adhya
SL, eds. Phages: Their Role in Bacterial Pathogenesis and Biotechnology. Washington, DC: ASM Press 2005:430-440.
Reprinted with permission from US Pharmacist, October 2008, US Pharm 2008 33(10):46-51. Copyright © 2008 Jobson
Medical Information LLC.